High incidence of fungus infections in renal transplantation patients treated with antilymphocyte and conventional immunosuppression.
D000666:Amphotericin B / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D001230:Aspergillus / Q000302:isolation & purification; D001379:Azathioprine / Q000627:therapeutic use; D003455:Cryptococcus neoformans / Q000302:isolation & purification; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D009615:Nocardia / Q000302:isolation & purification; D011241:Prednisone / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D013411:Sulfadiazine; D000666:Amphotericin B; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone